IndusInd Bank and Hero MotoCorp may be dropped from the Nifty50 in the September review, with Max Healthcare and IndiGo ...

Brokerage firms are bullish on Inox Wind, Gabriel India, and Metropolis Healthcare, citing strong growth prospects. Motilal ...

IndiGo has already rallied significantly, reflecting market anticipation. In contrast, Max Healthcare appears under-owned in this context and could attract stronger buying interest.

Aurobindo Pharma's subsidiary, CuraTeQ Biologics, secured European Commission approval for its trastuzumab biosimilar, ...